Literature DB >> 9234199

GABAA receptor-mediated IPSCs in rat thalamic sensory nuclei: patterns of discharge and tonic modulation by GABAB autoreceptors.

Y Le Feuvre1, D Fricker, N Leresche.   

Abstract

1. The patterns of discharge of spontaneous GABAA-mediated inhibitory postsynaptic currents (sIPSCs), originating from the nucleus reticularis thalami (NRT), and their modulation by GABAB autoreceptors, were studied in rat thalamocortical (TC) neurones using whole-cell voltage-clamp recordings in brain slices. 2. sIPSCs were recorded in all ventro-basal (VB) and dorsal lateral geniculate (LGN) neurones. In VB neurones, in the presence of tetraethylammonium (TEA, 5 mM), these sIPSCs can occur in bursts at frequencies of either 0.1 or 1-2 Hz. In the presence of tetrodotoxin (TTX), these bursting activities are replaced by the continuous discharge of miniature IPSCs (mIPSCs), recorded in the absence of TEA, at a frequency of 4 Hz. The kinetic properties of mIPSCs were similar in VB and LGN TC neurones. 3. In VB TC neurones the GABAB receptor agonist (+/-)-baclofen, at a concentration of 0.05 microM, decreased the mIPSC frequency by 22% without affecting their amplitude distribution. Increasing the (+/-)-baclofen concentration to 1 and 10 microM caused similar reductions (41 and 47%, respectively) in the mIPSCs frequency: these values were significantly different from the one observed with 0.05 microM (+/-)-baclofen. In LGN TC neurones, where mIPSCs originate from both NRT and local interneurone terminals, 1 microM (+/-)-baclofen produced a 66% reduction in the mIPSC frequency. 4. The GABAB receptor antagonist CGP55845A (50 nM) not only blocked the baclofen-mediated decrease in mIPSC frequency, but also produced a 52% increase in the mIPSC frequency compared with control in three out of seven neurones. Application of CGP55845A (50-500 nM) alone produced a 77% increase in the mIPSC frequency in three out of nine VB neurones, and in the LGN, CGP55845A (100 nM) produced a 53% increase in four out of nine neurones. CGP55845A (100 nM) also reversibly increased the amplitude of evoked GABAA IPSCs by 74 and 57% in three out of three VB and three out of five LGN neurones, respectively. 5. Application of GABA (1.5-5 microM) decreased the mIPSC frequency in VB TC neurones by a similar extent (48%) as 1-10 microM (+/-)-baclofen. 6. In the presence of 100 microM Cd2+, (+/-)-baclofen still decreased the mIPSC frequency by about 40%, indicating that the effect of presynaptic GABAB receptor activation on spontaneous GABA release did not occur through a reduction of voltage-dependent Ca2+ currents. 7. Cd2+ (100 microM) decreased the amplitude of both mIPSCs and isoguvacine-induced current by 30 and 19%, respectively, indicating an effect of this divalent cation on postsynaptic GABAA receptors. 8. We conclude that GABAB autoreceptors are present on the GABAergic terminals within the thalamic sensory nuclei and that these receptors can be tonically activated by the ambient GABA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234199      PMCID: PMC1159574          DOI: 10.1111/j.1469-7793.1997.091bl.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  37 in total

1.  Distribution and kinetics of GABAB binding sites in rat central nervous system: a quantitative autoradiographic study.

Authors:  D C Chu; R L Albin; A B Young; J B Penney
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

2.  Spontaneous release of GABA activates GABAB receptors and controls network activity in the neonatal rat hippocampus.

Authors:  H A McLean; O Caillard; R Khazipov; Y Ben-Ari; J L Gaiarsa
Journal:  J Neurophysiol       Date:  1996-08       Impact factor: 2.714

3.  Neighboring cerebellar Purkinje cells communicate via retrograde inhibition of common presynaptic interneurons.

Authors:  P Vincent; A Marty
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

4.  Electrophysiology of neurons of lateral thalamic nuclei in cat: resting properties and burst discharges.

Authors:  M Deschênes; M Paradis; J P Roy; M Steriade
Journal:  J Neurophysiol       Date:  1984-06       Impact factor: 2.714

5.  Inhibitory synaptic currents in stellate cells of rat cerebellar slices.

Authors:  I Llano; H M Gerschenfeld
Journal:  J Physiol       Date:  1993-08       Impact factor: 5.182

6.  The axonal arborization of single thalamic reticular neurons in the somatosensory thalamus of the rat.

Authors:  D Pinault; J Bourassa; M Deschênes
Journal:  Eur J Neurosci       Date:  1995-01-01       Impact factor: 3.386

7.  Differential activation of GABAA and GABAB receptors by spontaneously released transmitter.

Authors:  T S Otis; I Mody
Journal:  J Neurophysiol       Date:  1992-01       Impact factor: 2.714

8.  Inhibitory synaptic potentials in guinea-pig substantia nigra dopamine neurones in vitro.

Authors:  M A Häusser; W H Yung
Journal:  J Physiol       Date:  1994-09-15       Impact factor: 5.182

9.  Involvement of intrathalamic GABAB neurotransmission in the control of absence seizures in the rat.

Authors:  Z Liu; M Vergnes; A Depaulis; C Marescaux
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

10.  Presynaptic inhibition of calcium-dependent and -independent release elicited with ionomycin, gadolinium, and alpha-latrotoxin in the hippocampus.

Authors:  M Capogna; B H Gähwiler; S M Thompson
Journal:  J Neurophysiol       Date:  1996-05       Impact factor: 2.714

View more
  17 in total

1.  The initiation of bursts in thalamic neurons and the cortical control of thalamic sensitivity.

Authors:  Alain Destexhe; Terrence J Sejnowski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-12-29       Impact factor: 6.237

2.  Functional properties of perigeniculate inhibition of dorsal lateral geniculate nucleus thalamocortical neurons in vitro.

Authors:  M V Sanchez-Vives; D A McCormick
Journal:  J Neurosci       Date:  1997-11-15       Impact factor: 6.167

3.  Presynaptic and extrasynaptic regulation of posterior nucleus of thalamus.

Authors:  Anthony Park; Ying Li; Radi Masri; Asaf Keller
Journal:  J Neurophysiol       Date:  2017-03-22       Impact factor: 2.714

4.  Depression of glutamate and GABA release by presynaptic GABAB receptors in the entorhinal cortex in normal and chronically epileptic rats.

Authors:  Sarah E Thompson; Goher Ayman; Gavin L Woodhall; Roland S G Jones
Journal:  Neurosignals       Date:  2007-01-11

5.  Estimation of ambient GABA levels in layer I of the mouse neonatal cortex in brain slices.

Authors:  Anton Dvorzhak; Olga Myakhar; Petr Unichenko; Knut Kirmse; Sergei Kirischuk
Journal:  J Physiol       Date:  2010-04-26       Impact factor: 5.182

6.  GABAB Receptors Regulate Extrasynaptic GABAA Receptors.

Authors:  William M Connelly; Sarah J Fyson; Adam C Errington; Cian P McCafferty; David W Cope; Giuseppe Di Giovanni; Vincenzo Crunelli
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

7.  Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures.

Authors:  Nicolas Gervasi; Zohreh Monnier; Pierre Vincent; Daniele Paupardin-Tritsch; Stuart W Hughes; Vincenzo Crunelli; Nathalie Leresche
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

8.  On the action of the anti-absence drug ethosuximide in the rat and cat thalamus.

Authors:  N Leresche; H R Parri; G Erdemli; A Guyon; J P Turner; S R Williams; E Asprodini; V Crunelli
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

9.  GABA B receptor modulation of excitatory and inhibitory synaptic transmission onto rat CA3 hippocampal interneurons.

Authors:  Saobo Lei; Chris J McBain
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

10.  Enhanced tonic GABAA inhibition in typical absence epilepsy.

Authors:  David W Cope; Giuseppe Di Giovanni; Sarah J Fyson; Gergely Orbán; Adam C Errington; Magor L Lorincz; Timothy M Gould; David A Carter; Vincenzo Crunelli
Journal:  Nat Med       Date:  2009-11-22       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.